Graft Engineering: The Evolution of Hematopoietic Transplantation
- 1 January 1992
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 1 (1) , 3-17
- https://doi.org/10.1089/scd.1.1992.1.3
Abstract
In vivo therapeutic manipulation as well as ex vivo grafting are important strategies for bone marrow manipulation and transplantation. This review article discusses the early techniques for marrow processing and manipulation as a background for discussing later graft engineering protocols, as well as preclinical and experimental protocols designed to modify transplantation biology at the multidisciplinary level. The direction of future trials in graft transplantation is also discussed.Keywords
This publication has 44 references indexed in Scilit:
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Antigen CD34+ marrow cells engraft lethally irradiated baboons.Journal of Clinical Investigation, 1988
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987
- Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantationArchives of Dermatology, 1987
- RELATIONSHIP OF CELL DOSE AND FREEZING RATE TO RECONSTITUTE POTENCY IN A HEMATOPOIETIC RECONSTITUTION MODELTransplantation, 1987
- Autologous transplantation with circulating hemopoietic stem cellsJournal of Clinical Apheresis, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- DEVELOPMENT OF A SIMPLIFIED COUNTERFLOW CENTRIFUGATION ELUTRIATION PROCEDURE FOR DEPLETION OF LYMPHOCYTES FROM HUMAN BONE MARROWTransplantation, 1986
- QUANTITATION OF T LYMPHOCYTES IN HUMAN BONE MARROW BY A LIMITING DILUTION ASSAYTransplantation, 1985
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982